Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LOFEXIDINE vs LOMITAPIDE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LOFEXIDINE vs LOMITAPIDE: Safety Overview

Metric LOFEXIDINE LOMITAPIDE
Total FAERS Reports 139 3,779
Deaths Reported 0 109
Death Rate N/A 2.9%
Hospitalizations 17 434
Average Patient Age 47.5 yrs 54.6 yrs
% Female Patients 51.8% 66.5%
FDA Approval Date Aug 20, 2024 Apr 23, 2015
Manufacturer Prasco Laboratories Amryt Pharmaceuticals DAC
Route ORAL ORAL
Marketing Status Prescription Prescription